woman sitting in chair with notepad
June 9, 2021

UW Medicine was one of the clinical trial sites for aducanumab, a drug approved yesterday by the Food and Drug Administration to slow the progression of Alzheimer’s disease in people with mild symptoms.

June 1, 2021

Second round of funding focuses on technology-driven solutions to relieve burdens of cognitive aging, trauma and addiction.

October 28, 2020

Research program analyzes cerebrospinal fluid molecules to seek diagnostic and progression markers as well as treatment targets.

June 8, 2021

Dr. Thomas Grabowski, who directs the UW Medicine Alzheimer Disease Research Center, discusses latest advances and research in progress.

December 18, 2019

Researchers discover impact of MSUT2 gene and binding protein, offering others a starting point for new therapeutics.

Woman in a wheelchair
December 18, 2019

When it comes to preventing Alzheimer's disease, tau could be the answer. Brian Kraemer, a research associate professor of medicine in the Division of

October 28, 2019

UW Medicine and Kaiser Permanente researchers to study whether degenerative eye diseases offer clues to who will develop Alzheimer’s.

Mike and Lynn Garvey
October 3, 2019

UW Medicine is creating the Garvey Institute for Brain Health Solutions to develop effective new treatments for brain disorders, with foundational funding of $50 million from philanthropists Lynn and Mike Garvey.

October 3, 2019

Philanthropists Lynn and Mike Garvey establish The Garvey Institute for Brain Health Solutions to investigate the effects of aging, trauma and addiction.

December 4, 2018

'Alzheimer's, like breast cancer, is not one disease,' says UW Medicine dementia expert Shubhabrata Mukherjee.


Subscribe to Alzheimer's